The January edition of the IBA newsletter focuses on opportunities for professional growth and expanding expertise in clinical research and data analysis. The main theme highlights a range of specialized training programs designed for the healthcare, pharmaceutical, and clinical research industries.
In this lecture, we shall explore the challenges posed to clinical research (clinical trials, studies, and patient registries) by compromised data quality, and the technical solutions developed to tackle them. We shall showcase CLADE-IS, a unique system for clinical data management ranging from databasing to the use of ensemble learning, developed through in-house R&D at the Institute of Biostatistics and Analyses
He will be one of the speakers at the prestigious Medical 3D-Printing and Innovative Technologies Conference, taking place on November 29–30, 2024, at the General Hospital in Vienna. The conference focuses on the impact of innovative technologies on clinical practice, both nationally and internationally.
On November 5, 2024, another popular "Research Breakfast" took place at the Faculty of Medicine, Masaryk University.
Participation in Václav Moravec's Focus TV program "Frontiers of Medicine" introduced the Institute of Biostatistics and Analysis as a major player in the field of innovative use of AI in medicine.
The end of the year is marked by conferences where we participate either as participants, speakers or co-organizers.
The Institute of Biostatistics and Analyses is an investigator of the project “Extending services portfolio of an information system for the data management in clinical research”. The project is supported by the OP EIC from the European Union funds.
Main objective of the project is the development of a platform for composition of information systems focused on data management and data mining in the field of pharmaceutical industry and life sciences. Offer of digital services based on a developed and validated information system will make reliable analytical models accessible to the companies for their decision-making and precise information sources for regulatory bodies. The project steps out of a laboratory environment of clinical trials and focuses on the evidence supported by real-world data.
